As originally proposed by J.B.S. Haldane, infectious diseases are a major driving force of natural selection (Haldane, 1949), occasionally precipitating ‘catastrophic-selection’ events: the replacement of an entire, susceptible, parental population by mutant offspring that are resistant to a given infectious disease (Lewis, 1962). Such an event is proposed to have occurred during primate evolution between 20–30 million‐years‐ago, possibly due to the selective pressure exerted by an airborne, enveloped virus carrying Galα1-3Galβ1-4GlcNAc (αGal)-like glycans (Galili, 2016; Galili, 2019). If proven correct, this would contribute to the evolutionary pressure that led to the selection and fixation of GGTA1 loss-of-function mutations in ancestral primates (Galili et al., 1988).

Loss of the α1,3-galactosyltransferase enzyme, encoded by GGTA1, eliminated the expression of protein-bound αGal, allowing for immune targeting of this non-self glycan (Galili et al., 1987). This increased resistance to infection by αGal-expressing pathogens (Repik et al., 1994; Takeuchi et al., 1996), including parasites of the Plasmodium spp. (Soares and Yilmaz, 2016; Yilmaz et al., 2014), which exerted a major impact on human evolution (Allison, 1954).

We recently uncovered a possible fitness advantage associated with loss of GGTA1 function, which acts independently of αGal-specific immunity (Singh et al., 2021). Namely, loss of αGal from immunoglobulin (Ig)G-associated glycan structures increased IgG effector function and resistance to bacterial sepsis in mice (Singh et al., 2021).

Sepsis is a life-threatening organ dysfunction caused by a deregulated response to infection (Singer et al., 2016) that accounts for 20% of global human mortality (Rudd et al., 2020). The pathogenesis of sepsis is modulated by stable host symbiotic associations with microbial communities composed of bacteria, fungi, and viruses, known as the microbiota (Rudd et al., 2020; Vincent et al., 2009). While host-microbiota interactions provide a broad range of fitness advantages to the host (Lane-Petter, 1962; Vonaesch et al., 2018), these also carry fitness costs, for example, when bacterial pathobionts (Chow et al., 2011) translocate across host epithelial barriers to elicit the development of sepsis (Rudd et al., 2020; Vincent et al., 2009). On the basis of this evolutionary trade-off (Stearns and Medzhitov, 2015), it has been argued that the immune system may have emerged, in part, to mitigate the pathogenic effects of the microbiota (Hooper et al., 2012; McFall-Ngai, 2007). Central to this host defence strategy is the transepithelial secretion of copious amounts of IgA natural antibodies (NAb), which target immunogenic bacteria in the microbiota (Macpherson et al., 2000).

IgA recognize a broad but defined subset of immunogenic bacteria in the gut microbiota (Bunker et al., 2017; Bunker et al., 2015; Macpherson et al., 2000), exerting negative or positive selection pressure on these bacteria, shaping the microbiota composition, ecology, and potentially its pathogenicity (Kubinak and Round, 2016). Negative selection can occur, for example, when IgA limits bacterial growth (Moor et al., 2017), while positive selection can occur, for example, when IgA promotes bacterial interactions with the host, favoring bacterial retention, fitness, and colonization (Donaldson et al., 2018; McLoughlin et al., 2016). Moreover, IgA can interfere with cognate interactions between bacteria and tissue resident immune cells at epithelial barriers, regulating microbiota-specific immune responses, including the production of circulating IgM and IgG NAb (Kamada et al., 2015; Zeng et al., 2016).

Here, we provide experimental evidence in mice to suggest that the fixation of GGTA1 loss-of-function mutations during primate evolution exerted a major impact on the composition of their gut microbiota. In support of this notion, mice in which Ggta1 is disrupted (Ggta1^-/-), mimicking human GGTA1 loss-of-function mutations, modulated their gut microbiota composition. This occurs predominantly via an Ig-dependent mechanism, associated with an enhancement of the production of IgA, targeting αGal-expressing bacteria in the gut microbiota. The pathogenicity of the Ig-shaped microbiota is reduced, failing to elicit lethal forms of sepsis upon systemic infection. We propose that GGTA1 loss-of-function mutations conferred a selective benefit during primate evolution, in part, by shaping commensal bacteria in the microbiota to mitigate the pathogenesis of sepsis.

While loss-of-function mutations in genes encoding glycosyltransferases can provide fitness advantages against infection, these can compromise the physiologic functions of the eliminated self-glycan, as illustrated by the occurrence of reproductive senescence upon Ggta1 deletion in mice (Singh et al., 2021). In an evolutionary context, such a trade-off could explain why loss-of-function mutations in these genes are rare, and in some cases unique, to the human lineage. The latter is illustrated by the loss of CMP-N-acetylneuraminic acid hydroxylase (CMAH) function, which eliminated expression of the sialic acid, N-glycolylneuraminic acid (Neu5Gc), in humans (Ghaderi et al., 2011).

Co-evolution of ancestral hominids with commensal bacteria in their microbiota (Dethlefsen et al., 2007; Huttenhower et al., 2012; Moeller et al., 2016), is thought to have provided a series of fitness advantages including, among others, optimization of nutrient intake from diet, regulation of different aspects of organismal metabolism or colonization resistance against pathogenic bacteria (Buffie and Pamer, 2013). Here we propose that the loss of αGal expression, as it occurred during primate evolution, might have exerted a major impact on the nature of these symbiotic associations. In support of this notion, we found that Ggta1 deletion in mice was associated with major changes in the composition of the gut microbiota (Figure 1). This occurred over several generations under experimental conditions of exposure to environmental-derived pathobionts, and minimum relative impact exerted by other environmental factors on microbiota composition (Ubeda et al., 2012), arguing that the Ggta1 genotype modulates the microbiota composition. On the basis of this observation alone (Figure 1), one cannot exclude the observed divergence in the microbiota bacterial population frequencies harbored by wild type vs. Ggta1-deleted mice (Figure 1) from being a stochastic event. However, the observation that these changes occur via an Ig-dependent mechanism that differs in wild type vs. Ggta1-deleted mice (Figure 3) does suggest that loss of αGal contributes critically to shape the microbiota composition of Ggta1-deleted mice.

While our studies do not provide direct evidence that the loss of αGal played a major role in shaping the microbiota composition of Old- vs. New World primates, this notion is supported, indirectly, by the recent finding that mutations altering the expression of human ABO blood group glycans are associated with shaping of the bacterial composition of the gut microbiota (Rühlemann et al., 2021). In light of the structural similarity between the human B blood group (i.e. Galα1-3(Fucα1-2)Galβ1-4GlcNAcβ1-R), and αGal (i.e. Galα1-3Galβ1-4GlcNAcβ1-R) glycans, our findings probably reflect a general mechanism whereby host ‘αGal-like’ glycans shape the microbiota composition of mice and primates, including that of humans. Whether or not this is the case, considering that microbiota composition is shaped mostly by environmental factors, remains to be formally established.

The mechanism via which Ggta1 deletion shapes the gut microbiota is associated with targeting of αGal-expressing bacteria by IgA (Figure 2). Consistent with this notion, a relatively large proportion of probiotic bacteria as well as bacteria present in the mouse microbiota express αGal-like glycans at the cell surface (Figure 2). About 30% of these carry IgA at the cell surface in the mouse microbiota and, as such, are considered as immunogenic (Palm et al., 2014). The proportion of IgA⁺αGal⁺ bacteria was reduced in the microbiota of Ggta1-deleted mice and was presumably eliminated (Figure 2). This suggests that Ggta1 deletion probably broadens bacterial recognition by IgA to include immunogenic αGal⁺ bacteria, which as a result are probably purged from the microbiota. Whether this occurs via a mechanism involving the recognition of αGal-like glycans, and/or other related epitopes expressed at the surface of these bacteria, by IgA, has not been established. Of note, these are not mutually exclusive possibilities since: (i) IgA can target αGal-like glycans and modulate bacterial pathogenicity (Hamadeh et al., 1995), (ii) IgA are poly-reactive and can target common antigens expressed by bacteria (Bunker et al., 2017; Bunker et al., 2015) and (iii) αGal-reactive antibodies present a degree of poly-reactivity against non-αGal related bacterial epitopes (Bernth Jensen et al., 2021).

The identity of the αGal⁺ bacteria targeted by IgA remains elusive but likely includes Gram-negative pathobionts from the Enterobacteriaceae family, as demonstrated for Escherichia (E.) coli O86:B7 (Yilmaz et al., 2014), which expresses the αGal-like glycan Galα1-3Gal(Fucα1–2)β1-3GlcNAcβ1-4Glc as part of the lipopolysaccharide (LPS) O-antigen (Guo et al., 2005). Of note, this pathobiont can induce a systemic αGal-specific NAb response in humans (Springer and Horton, 1969) as well as in Ggta1-deleted mice, which is protective against infection by pathogens expressing αGal-like glycans (Yilmaz et al., 2014). The finding that several commensal bacteria in the human gut microbiota express αGal-like glycans (Figure 2—figure supplement 2) suggests that other bacteria might contribute to this protective response.

Our findings also suggest that Ggta1 deletion shapes the bacterial community structure among highly abundant bacterial taxa in the microbiota via an Ig-dependent mechanism, and among low abundant bacterial taxa independently of Ig (Figure 3). Presumably, shaping of highly abundant taxa by Ig occurs via a mechanism that involves not only IgA produced by the offspring, but also maternal IgG transferred through the placenta as well as IgM, IgG, and IgA transferred through maternal milk (Koch et al., 2016). These regulate neonatal innate (Gomez de Agüero et al., 2016) and adaptive (Koch et al., 2016) immunity, shaping the offspring microbiota composition (Gensollen et al., 2016; Koch et al., 2016). Whether this occurs via targeting of αGal-like glycans, as discussed above, and/or via other bacterial antigens expressed by immunogenic bacteria has not been established.

Shaping of lowly abundant bacterial taxa independently of Ig (Figure 3) suggests that other mechanisms contribute to shaping the microbiota of Ggta1-deleted mice. These probably include the modulation of nutritional or spatial niches due to the loss of αGal from complex glycosylated structures present at epithelial barriers, such as the mucus, as demonstrated for other glycans (Pickard et al., 2014).

The selective pressure exerted by the adaptive immune system of Ggta1^-/- mice on the bacterial species present in the microbiota, probably allows for the establishment of a more diverse ecosystem containing pathobionts (Singh et al., 2021), such as Helicobactereaceae (Figure 1—figure supplements 1 and 2). These can elicit the production of antibodies targeting and exerting negative selective pressure on other bacterial symbionts and releasing ecological niches, thus further shaping the microbiota. Expansion of these pathobionts in the microbiota of Ggta1^-/- mice is restrained by Ig, which probably explains the lack of associated pathology (Figure 1—figure supplement 3). This suggests that the loss of GGTA1 function in ancestral primates fostered mutualistic interactions with more diverse bacterial ecosystems, incorporating pathobionts such as Helicobacter pylori, associated with fitness costs (Atherton and Blaser, 2009) and gains (Linz et al., 2007).

Our findings suggest that Ig-shaping of the bacterial species present in the gut microbiota of Ggta1^-/- mice reduces the microbiota pathogenicity, as illustrated when comparing the lethal outcome of systemic infections using the Ig-shaped vs. non-shaped microbiota (Figure 4A, Figure 4—figure supplement 1A and B). This reduction in pathogenicity means that the effector mechanism underlying resistance against systemic infection by the Ig-shaped microbiota no longer relies on the adaptive immune system (Figure 4—figure supplement 1C and E), but instead on cellular components of the innate immune systems, namely, neutrophils (Figure 4G,H).

We propose that Ggta1 deletion in mice increases resistance to bacterial sepsis via two distinct antibody-dependent mechanisms. The first involves a relative increase in antibody effector function, when αGal is not present in the biantennary glycan structures of IgG (Singh et al., 2021). The second relies on shaping and reduction of the microbiota pathogenicity by antibodies, most likely from the IgA isotype. To what extent the lack of αGal from the biantennary glycan structures of Ig also contributes to shape and reduce the microbiota pathogenicity, remains to be established. It is possible however, that similar to IgG (Singh et al., 2021), the absence of αGal from the glycan structures of different Ig isotypes, including IgA, modulates their effector function, when targeting immunogenic bacteria in the microbiota.

The notion of host mechanisms shaping the microbiota composition toward a reduction of its pathogenicity is in keeping with host microbial interactions not being hardwired, but instead shifting between symbiotic to pathogenic depending on host and microbe cooperative behaviors (Ayres, 2016; Vonaesch et al., 2018). For example, when restricted to the microbiota, bacterial pathobionts can behave as commensals, posing no pathogenic threat to the host (Vonaesch et al., 2018), while triggering sepsis (Haak and Wiersinga, 2017) upon translocation across epithelial barriers (Caruso et al., 2020). The high fitness cost imposed to modern humans by sepsis (Rudd et al., 2020) suggests that mutations shaping the composition of the microbiota toward a reduced capacity to elicit sepsis should be associated with major fitness advantages. Our findings suggest that loss-of-function mutations in GGTA1 act in such a manner.

When challenged experimentally with a bacterial inoculum or bacterial lipopolysaccharide (LPS), non-human primates appear to be far more susceptible to develop sepsis or septic shock, respectively, as compared to other mammalian lineages (Chen et al., 2019). This may appear at odds with our interpretation that similar to Ggta1 deletion in mice (Figure 4; Singh et al., 2021), the evolutionary loss of GGTA1 function in Old-World primates might have increased resistance to bacterial sepsis (Singh et al., 2021). One likely explanation for this apparent discrepancy may relate to the intrinsic properties of primate immunity, whereby natural selection of traits enhancing immune-driven resistance mechanisms (Olson, 1999; Wang et al., 2006) might be associated with lower capacity to establish disease tolerance to infection (Martins et al., 2019; Medzhitov et al., 2012). This interpretation is consistent with resistance and disease tolerance to infection being negatively correlated (Råberg et al., 2007), such that traits increasing resistance might be associated with a reduction in disease tolerance, as an evolutionary trade-off.

In conclusion, protective immunity against αGal-expressing pathogens was likely a major driving force in the natural selective events that led to the fixation of loss-of-function mutations in the GGTA1 gene of ancestral Old World primates (Galili, 2016; Soares and Yilmaz, 2016). Moreover, in the absence of αGal, the glycan structures associated with the Fc portion of IgG, can increase IgG-effector function and resistance to bacterial infections, irrespectively of αGal-specific immunity (Singh et al., 2021). The net survival advantage against infection provided by these traits came alongside the emergence of reproductive senescence (Singh et al., 2021), a major fitness cost presumably outweighed by endemic exposure to highly virulent pathogens (Singh et al., 2021). Here we provide experimental evidence for yet another fitness advantage against infection, associated with the loss of GGTA1, driven by Ig-shaping and reduction of microbiota pathogenicity. We infer that ancestral Old World primates carrying loss-of-function mutations in GGTA1 probably shaped their microbiota to minimize its pathogenic effect, providing a major fitness advantage against sepsis.

All data generated during this study are included in the manuscript and supporting files. The 16S sequencing data can be accessed via NCBI Bioproject PRJNA701192.

1. 1. Soares M
   2. Singh S
   3. Bastos-Amador P
   4. Thompson JA
   5. Yilmaz B
   6. Cardoso S
   7. Sobral D

   (2021) NCBI BioProject

   ID PRJNA701192. GLYCAN-BASED SHAPING OF THE MICROBIOTA DURING PRIMATE EVOLUTION.

   https://www.ncbi.nlm.nih.gov/bioproject/PRJNA701192

1. 1. Allison AC

   (1954) Protection afforded by sickle-cell trait against subtertian malareal infection

   BMJ 1:290–294.

   https://doi.org/10.1136/bmj.1.4857.290

   • PubMed
   • Google Scholar
2. 1. Atherton JC
   2. Blaser MJ

   (2009) Coadaptation of Helicobacter pylori and humans: ancient history, modern implications

   Journal of Clinical Investigation 119:2475–2487.

   https://doi.org/10.1172/JCI38605

   • PubMed
   • Google Scholar
3. 1. Ayres JS

   (2016) Cooperative microbial tolerance behaviors in Host-Microbiota mutualism

   Cell 165:1323–1331.

   https://doi.org/10.1016/j.cell.2016.05.049

   • PubMed
   • Google Scholar
4. 1. Bernth Jensen JM
   2. Skeldal S
   3. Petersen MS
   4. Møller BK
   5. Hoffmann S
   6. Jensenius JC
   7. Skov Sørensen UB
   8. Thiel S

   (2021) The human natural anti-αGal antibody targets common pathogens by broad-spectrum polyreactivity

   Immunology 162:434–451.

   https://doi.org/10.1111/imm.13297

   • PubMed
   • Google Scholar
5. 1. Buffie CG
   2. Pamer EG

   (2013) Microbiota-mediated colonization resistance against intestinal pathogens

   Nature Reviews Immunology 13:790–801.

   https://doi.org/10.1038/nri3535

   • PubMed
   • Google Scholar
6. 1. Bunker JJ
   2. Flynn TM
   3. Koval JC
   4. Shaw DG
   5. Meisel M
   6. McDonald BD
   7. Ishizuka IE
   8. Dent AL
   9. Wilson PC
   10. Jabri B
   11. Antonopoulos DA
   12. Bendelac A

   (2015) Innate and adaptive humoral responses coat distinct commensal Bacteria with immunoglobulin A

   Immunity 43:541–553.

   https://doi.org/10.1016/j.immuni.2015.08.007

   • PubMed
   • Google Scholar
7. 1. Bunker JJ
   2. Erickson SA
   3. Flynn TM
   4. Henry C
   5. Koval JC
   6. Meisel M
   7. Jabri B
   8. Antonopoulos DA
   9. Wilson PC
   10. Bendelac A

   (2017) Natural polyreactive IgA antibodies coat the intestinal Microbiota

   Science 358:eaan6619.

   https://doi.org/10.1126/science.aan6619

   • PubMed
   • Google Scholar
8. 1. Caporaso JG
   2. Kuczynski J
   3. Stombaugh J
   4. Bittinger K
   5. Bushman FD
   6. Costello EK
   7. Fierer N
   8. Peña AG
   9. Goodrich JK
   10. Gordon JI
   11. Huttley GA
   12. Kelley ST
   13. Knights D
   14. Koenig JE
   15. Ley RE
   16. Lozupone CA
   17. McDonald D
   18. Muegge BD
   19. Pirrung M
   20. Reeder J
   21. Sevinsky JR
   22. Turnbaugh PJ
   23. Walters WA
   24. Widmann J
   25. Yatsunenko T
   26. Zaneveld J
   27. Knight R

   (2010) QIIME allows analysis of high-throughput community sequencing data

   Nature Methods 7:335–336.

   https://doi.org/10.1038/nmeth.f.303

   • PubMed
   • Google Scholar
9. 1. Caruso R
   2. Lo BC
   3. Núñez G

   (2020) Host-microbiota interactions in inflammatory bowel disease

   Nature Reviews Immunology 20:411–426.

   https://doi.org/10.1038/s41577-019-0268-7

   • PubMed
   • Google Scholar
10. 1. Chassaing B
    2. Srinivasan G
    3. Delgado MA
    4. Young AN
    5. Gewirtz AT
    6. Vijay-Kumar M

    (2012) Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation

    PLOS ONE 7:e44328.

    https://doi.org/10.1371/journal.pone.0044328

    • PubMed
    • Google Scholar
11. 1. Chen L
    2. Welty-Wolf KE
    3. Kraft BD

    (2019) Nonhuman primate species as models of human bacterial Sepsis

    Lab Animal 48:57–65.

    https://doi.org/10.1038/s41684-018-0217-2

    • Google Scholar
12. 1. Chow J
    2. Tang H
    3. Mazmanian SK

    (2011) Pathobionts of the gastrointestinal Microbiota and inflammatory disease

    Current Opinion in Immunology 23:473–480.

    https://doi.org/10.1016/j.coi.2011.07.010

    • PubMed
    • Google Scholar
13. 1. Daley JM
    2. Thomay AA
    3. Connolly MD
    4. Reichner JS
    5. Albina JE

    (2008) Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice

    Journal of Leukocyte Biology 83:64–70.

    https://doi.org/10.1189/jlb.0407247

    • PubMed
    • Google Scholar
14. 1. DeSantis TZ
    2. Hugenholtz P
    3. Larsen N
    4. Rojas M
    5. Brodie EL
    6. Keller K
    7. Huber T
    8. Dalevi D
    9. Hu P
    10. Andersen GL

    (2006) Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB

    Applied and Environmental Microbiology 72:5069–5072.

    https://doi.org/10.1128/AEM.03006-05

    • PubMed
    • Google Scholar
15. 1. Dethlefsen L
    2. McFall-Ngai M
    3. Relman DA

    (2007) An ecological and evolutionary perspective on human-microbe mutualism and disease

    Nature 449:811–818.

    https://doi.org/10.1038/nature06245

    • PubMed
    • Google Scholar
16. 1. Ding JW
    2. Zhou T
    3. Zeng H
    4. Ma L
    5. Verbeek JS
    6. Yin D
    7. Shen J
    8. Chong AS

    (2008) Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors

    J Immunol.  180:261–268.

    https://doi.org/10.4049/jimmunol.180.1.261

    • Google Scholar
17. 1. Donaldson GP
    2. Ladinsky MS
    3. Yu KB
    4. Sanders JG
    5. Yoo BB
    6. Chou WC
    7. Conner ME
    8. Earl AM
    9. Knight R
    10. Bjorkman PJ
    11. Mazmanian SK

    (2018) Gut Microbiota utilize immunoglobulin A for mucosal colonization

    Science 360:795–800.

    https://doi.org/10.1126/science.aaq0926

    • PubMed
    • Google Scholar
18. 1. Fagarasan S
    2. Kawamoto S
    3. Kanagawa O
    4. Suzuki K

    (2010) Adaptive immune regulation in the gut: t cell-dependent and T cell-independent IgA synthesis

    Annual Review of Immunology 28:243–273.

    https://doi.org/10.1146/annurev-immunol-030409-101314

    • PubMed
    • Google Scholar
19. 1. Galili U
    2. Clark MR
    3. Shohet SB
    4. Buehler J
    5. Macher BA

    (1987) Evolutionary relationship between the natural anti-Gal antibody and the gal alpha 1----3gal epitope in primates

    PNAS 84:1369–1373.

    https://doi.org/10.1073/pnas.84.5.1369

    • PubMed
    • Google Scholar
20. 1. Galili U
    2. Shohet SB
    3. Kobrin E
    4. Stults CL
    5. Macher BA

    (1988) Man, apes, and old world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells

    Journal of Biological Chemistry 263:17755–17762.

    https://doi.org/10.1016/S0021-9258(19)77900-9

    • PubMed
    • Google Scholar
21. 1. Galili U

    (2016) Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?

    Glycobiology 142:1140–1150.

    https://doi.org/10.1093/glycob/cww088

    • Google Scholar
22. 1. Galili U

    (2019) Evolution in primates by "Catastrophic-selection" interplay between enveloped virus epidemics, mutated genes of enzymes synthesizing carbohydrate antigens, and natural anti-carbohydrate antibodies

    American Journal of Physical Anthropology 168:352–363.

    https://doi.org/10.1002/ajpa.23745

    • PubMed
    • Google Scholar
23. 1. Gálvez EJC
    2. Iljazovic A
    3. Gronow A
    4. Flavell R
    5. Strowig T

    (2017) Shaping of intestinal Microbiota in Nlrp6- and Rag2-Deficient mice depends on community structure

    Cell Reports 21:3914–3926.

    https://doi.org/10.1016/j.celrep.2017.12.027

    • PubMed
    • Google Scholar
24. 1. Gensollen T
    2. Iyer SS
    3. Kasper DL
    4. Blumberg RS

    (2016) How colonization by Microbiota in early life shapes the immune system

    Science 352:539–544.

    https://doi.org/10.1126/science.aad9378

    • PubMed
    • Google Scholar
25. 1. Ghaderi D
    2. Springer SA
    3. Ma F
    4. Cohen M
    5. Secrest P
    6. Taylor RE
    7. Varki A
    8. Gagneux P

    (2011) Sexual selection by female immunity against paternal antigens can fix loss of function alleles

    PNAS 108:17743–17748.

    https://doi.org/10.1073/pnas.1102302108

    • PubMed
    • Google Scholar
26. 1. Gomez de Agüero M
    2. Ganal-Vonarburg SC
    3. Fuhrer T
    4. Rupp S
    5. Uchimura Y
    6. Li H
    7. Steinert A
    8. Heikenwalder M
    9. Hapfelmeier S
    10. Sauer U
    11. McCoy KD
    12. Macpherson AJ

    (2016) The maternal Microbiota drives early postnatal innate immune development

    Science 351:1296–1302.

    https://doi.org/10.1126/science.aad2571

    • PubMed
    • Google Scholar
27. 1. Gu H
    2. Zou YR
    3. Rajewsky K

    (1993) Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting

    Cell 73:1155–1164.

    https://doi.org/10.1016/0092-8674(93)90644-6

    • PubMed
    • Google Scholar
28. 1. Guo H
    2. Yi W
    3. Shao J
    4. Lu Y
    5. Zhang W
    6. Song J
    7. Wang PG

    (2005) Molecular analysis of the O-antigen gene cluster of Escherichia coli O86:b7 and characterization of the chain length determinant gene (wzz)

    Applied and Environmental Microbiology 71:7995–8001.

    https://doi.org/10.1128/AEM.71.12.7995-8001.2005

    • PubMed
    • Google Scholar
29. 1. Haak BW
    2. Wiersinga WJ

    (2017) The role of the gut Microbiota in Sepsis

    The Lancet Gastroenterology & Hepatology 2:135–143.

    https://doi.org/10.1016/S2468-1253(16)30119-4

    • PubMed
    • Google Scholar
30. 1. Haldane JBS

    (1949) Disease and evolution

    Ricerca Scientifica 19:68–76.

    https://doi.org/10.1007/0-387-28295-5_9

    • Google Scholar
31. 1. Hamadeh RM
    2. Estabrook MM
    3. Zhou P
    4. Jarvis GA
    5. Griffiss JM

    (1995) Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing

    Infection and Immunity 63:4900–4906.

    https://doi.org/10.1128/IAI.63.12.4900-4906.1995

    • PubMed
    • Google Scholar
32. 1. Hooper LV
    2. Littman DR
    3. Macpherson AJ

    (2012) Interactions between the Microbiota and the immune system

    Science 336:1268–1273.

    https://doi.org/10.1126/science.1223490

    • PubMed
    • Google Scholar
33. 1. Huttenhower C
    2. Gevers D
    3. Knight R
    4. Abubucker S
    5. Badger JH
    6. Chinwalla AT
    7. Creasy HH
    8. Earl AM
    9. FitzGerald MG
    10. Fulton RS
    11. Human Microbiome Project Consortium

    (2012) Structure, function and diversity of the healthy human microbiome

    Nature 486:207–214.

    https://doi.org/10.1038/nature11234

    • PubMed
    • Google Scholar
34. 1. Kamada N
    2. Sakamoto K
    3. Seo SU
    4. Zeng MY
    5. Kim YG
    6. Cascalho M
    7. Vallance BA
    8. Puente JL
    9. Núñez G

    (2015) Humoral immunity in the gut selectively targets phenotypically virulent Attaching-and-Effacing Bacteria for intraluminal elimination

    Cell Host & Microbe 17:617–627.

    https://doi.org/10.1016/j.chom.2015.04.001

    • PubMed
    • Google Scholar
35. 1. Kawamoto S
    2. Maruya M
    3. Kato LM
    4. Suda W
    5. Atarashi K
    6. Doi Y
    7. Tsutsui Y
    8. Qin H
    9. Honda K
    10. Okada T
    11. Hattori M
    12. Fagarasan S

    (2014) Foxp3+ T cells regulate immunoglobulin A selection and facilitate diversification of bacterial species responsible for immune homeostasis

    Immunity 41:152–165.

    https://doi.org/10.1016/j.immuni.2014.05.016

    • PubMed
    • Google Scholar
36. 1. Koch MA
    2. Reiner GL
    3. Lugo KA
    4. Kreuk LS
    5. Stanbery AG
    6. Ansaldo E
    7. Seher TD
    8. Ludington WB
    9. Barton GM

    (2016) Maternal IgG and IgA antibodies dampen mucosal T helper cell responses in early life

    Cell 165:827–841.

    https://doi.org/10.1016/j.cell.2016.04.055

    • PubMed
    • Google Scholar
37. 1. Kubinak JL
    2. Round JL

    (2016) Do antibodies select a healthy Microbiota?

    Nature Reviews Immunology 16:767–774.

    https://doi.org/10.1038/nri.2016.114

    • PubMed
    • Google Scholar
38. 1. Lane-Petter W

    (1962) The provision and use of Pathogen-Free laboratory animals

    PNAS 55:253–263.

    https://doi.org/10.1177/003591576205500402

    • Google Scholar
39. 1. Lewis H

    (1962) Catastrophic selection as a factor in speciation

    Evolution 16:257–271.

    https://doi.org/10.1111/j.1558-5646.1962.tb03218.x

    • Google Scholar
40. 1. Linz B
    2. Balloux F
    3. Moodley Y
    4. Manica A
    5. Liu H
    6. Roumagnac P
    7. Falush D
    8. Stamer C
    9. Prugnolle F
    10. van der Merwe SW
    11. Yamaoka Y
    12. Graham DY
    13. Perez-Trallero E
    14. Wadstrom T
    15. Suerbaum S
    16. Achtman M

    (2007) An african origin for the intimate association between humans and Helicobacter pylori

    Nature 445:915–918.

    https://doi.org/10.1038/nature05562

    • PubMed
    • Google Scholar
41. 1. Lozupone C
    2. Knight R

    (2005) UniFrac: a new phylogenetic method for comparing microbial communities

    Applied and Environmental Microbiology 71:8228–8235.

    https://doi.org/10.1128/AEM.71.12.8228-8235.2005

    • PubMed
    • Google Scholar
42. 1. Macpherson AJ
    2. Gatto D
    3. Sainsbury E
    4. Harriman GR
    5. Hengartner H
    6. Zinkernagel RM

    (2000) A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal Bacteria

    Science 288:2222–2226.

    https://doi.org/10.1126/science.288.5474.2222

    • PubMed
    • Google Scholar
43. 1. Macpherson AJ
    2. Yilmaz B
    3. Limenitakis JP
    4. Ganal-Vonarburg SC

    (2018) IgA function in relation to the intestinal Microbiota

    Annual Review of Immunology 36:359–381.

    https://doi.org/10.1146/annurev-immunol-042617-053238

    • PubMed
    • Google Scholar
44. 1. Martins R
    2. Carlos AR
    3. Braza F
    4. Thompson JA
    5. Bastos-Amador P
    6. Ramos S
    7. Soares MP

    (2019) Disease tolerance as an inherent component of immunity

    Annual Review of Immunology 37:405–437.

    https://doi.org/10.1146/annurev-immunol-042718-041739

    • Google Scholar
45. 1. McFall-Ngai M

    (2007) Care for the community

    Nature 445:153.

    https://doi.org/10.1038/445153a

    • Google Scholar
46. 1. McLoughlin K
    2. Schluter J
    3. Rakoff-Nahoum S
    4. Smith AL
    5. Foster KR

    (2016) Host selection of Microbiota via differential adhesion

    Cell Host & Microbe 19:550–559.

    https://doi.org/10.1016/j.chom.2016.02.021

    • PubMed
    • Google Scholar
47. 1. Medzhitov R
    2. Schneider DS
    3. Soares MP

    (2012) Disease tolerance as a defense strategy

    Science 335:936–941.

    https://doi.org/10.1126/science.1214935

    • PubMed
    • Google Scholar
48. 1. Moeller AH
    2. Caro-Quintero A
    3. Mjungu D
    4. Georgiev AV
    5. Lonsdorf EV
    6. Muller MN
    7. Pusey AE
    8. Peeters M
    9. Hahn BH
    10. Ochman H

    (2016) Cospeciation of gut Microbiota with hominids

    Science 353:380–382.

    https://doi.org/10.1126/science.aaf3951

    • PubMed
    • Google Scholar
49. 1. Montassier E
    2. Al-Ghalith GA
    3. Mathé C
    4. Le Bastard Q
    5. Douillard V
    6. Garnier A
    7. Guimon R
    8. Raimondeau B
    9. Touchefeu Y
    10. Duchalais E
    11. Vince N
    12. Limou S
    13. Gourraud PA
    14. Laplaud DA
    15. Nicot AB
    16. Soulillou JP
    17. Berthelot L

    (2019) Distribution of bacterial α1,3-Galactosyltransferase genes in the human gut microbiome

    Frontiers in Immunology 10:3000.

    https://doi.org/10.3389/fimmu.2019.03000

    • PubMed
    • Google Scholar
50. 1. Moor K
    2. Diard M
    3. Sellin ME
    4. Felmy B
    5. Wotzka SY
    6. Toska A
    7. Bakkeren E
    8. Arnoldini M
    9. Bansept F
    10. Co AD
    11. Völler T
    12. Minola A
    13. Fernandez-Rodriguez B
    14. Agatic G
    15. Barbieri S
    16. Piccoli L
    17. Casiraghi C
    18. Corti D
    19. Lanzavecchia A
    20. Regoes RR
    21. Loverdo C
    22. Stocker R
    23. Brumley DR
    24. Hardt WD
    25. Slack E

    (2017) High-avidity IgA protects the intestine by enchaining growing Bacteria

    Nature 544:498–502.

    https://doi.org/10.1038/nature22058

    • PubMed
    • Google Scholar
51. 1. Olson MV

    (1999) When less is more: gene loss as an engine of evolutionary change

    The American Journal of Human Genetics 64:18–23.

    https://doi.org/10.1086/302219

    • PubMed
    • Google Scholar
52. 1. Palm NW
    2. de Zoete MR
    3. Cullen TW
    4. Barry NA
    5. Stefanowski J
    6. Hao L
    7. Degnan PH
    8. Hu J
    9. Peter I
    10. Zhang W
    11. Ruggiero E
    12. Cho JH
    13. Goodman AL
    14. Flavell RA

    (2014) Immunoglobulin A coating identifies colitogenic Bacteria in inflammatory bowel disease

    Cell 158:1000–1010.

    https://doi.org/10.1016/j.cell.2014.08.006

    • PubMed
    • Google Scholar
53. 1. Peterson DA
    2. McNulty NP
    3. Guruge JL
    4. Gordon JI

    (2007) IgA response to symbiotic Bacteria as a mediator of gut homeostasis

    Cell Host & Microbe 2:328–339.

    https://doi.org/10.1016/j.chom.2007.09.013

    • PubMed
    • Google Scholar
54. 1. Pickard JM
    2. Maurice CF
    3. Kinnebrew MA
    4. Abt MC
    5. Schenten D
    6. Golovkina TV
    7. Bogatyrev SR
    8. Ismagilov RF
    9. Pamer EG
    10. Turnbaugh PJ
    11. Chervonsky AV

    (2014) Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness

    Nature 514:638–641.

    https://doi.org/10.1038/nature13823

    • PubMed
    • Google Scholar
55. 1. Råberg L
    2. Sim D
    3. Read AF

    (2007) Disentangling genetic variation for resistance and tolerance to infectious diseases in animals

    Science 318:812–814.

    https://doi.org/10.1126/science.1148526

    • PubMed
    • Google Scholar
56. 1. Repik PM
    2. Strizki JM
    3. Galili U

    (1994) Differential host-dependent expression of alpha-galactosyl epitopes on viral glycoproteins: a study of eastern equine encephalitis virus as a model

    Journal of General Virology 75:1177–1181.

    https://doi.org/10.1099/0022-1317-75-5-1177

    • PubMed
    • Google Scholar
57. 1. Rudd KE
    2. Johnson SC
    3. Agesa KM
    4. Shackelford KA
    5. Tsoi D
    6. Kievlan DR
    7. Colombara DV
    8. Ikuta KS
    9. Kissoon N
    10. Finfer S
    11. Fleischmann-Struzek C
    12. Machado FR
    13. Reinhart KK
    14. Rowan K
    15. Seymour CW
    16. Watson RS
    17. West TE
    18. Marinho F
    19. Hay SI
    20. Lozano R
    21. Lopez AD
    22. Angus DC
    23. Murray CJL
    24. Naghavi M

    (2020) Global, regional, and national Sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study

    The Lancet 395:200–211.

    https://doi.org/10.1016/S0140-6736(19)32989-7

    • PubMed
    • Google Scholar
58. 1. Rühlemann MC
    2. Hermes BM
    3. Bang C
    4. Doms S
    5. Moitinho-Silva L
    6. Thingholm LB
    7. Frost F
    8. Degenhardt F
    9. Wittig M
    10. Kässens J
    11. Weiss FU
    12. Peters A
    13. Neuhaus K
    14. Völker U
    15. Völzke H
    16. Homuth G
    17. Weiss S
    18. Grallert H
    19. Laudes M
    20. Lieb W
    21. Haller D
    22. Lerch MM
    23. Baines JF
    24. Franke A

    (2021) Genome-wide association study in 8,956 german individuals identifies influence of ABO histo-blood groups on gut microbiome

    Nature Genetics 53:147–155.

    https://doi.org/10.1038/s41588-020-00747-1

    • PubMed
    • Google Scholar
59. 1. Singer M
    2. Deutschman CS
    3. Seymour CW
    4. Shankar-Hari M
    5. Annane D
    6. Bauer M
    7. Bellomo R
    8. Bernard GR
    9. Chiche JD
    10. Coopersmith CM
    11. Hotchkiss RS
    12. Levy MM
    13. Marshall JC
    14. Martin GS
    15. Opal SM
    16. Rubenfeld GD
    17. van der Poll T
    18. Vincent JL
    19. Angus DC

    (2016) The third international consensus definitions for Sepsis and septic shock (Sepsis-3)

    Jama 315:801–810.

    https://doi.org/10.1001/jama.2016.0287

    • PubMed
    • Google Scholar
60. 1. Singh S
    2. Thompson JA
    3. Yilmaz B
    4. Li H
    5. Weis S
    6. Sobral D
    7. Truglio M
    8. Aires da Silva F
    9. Aguiar S
    10. Carlos AR
    11. Rebelo S
    12. Cardoso S
    13. Gjini E
    14. Nuñez G
    15. Soares MP

    (2021) Loss of α-gal during primate evolution enhanced antibody-effector function and resistance to bacterial Sepsis

    Cell Host & Microbe 29:347–361.

    https://doi.org/10.1016/j.chom.2020.12.017

    • PubMed
    • Google Scholar
61. 1. Soares MP
    2. Yilmaz B

    (2016) Microbiota control of malaria transmission

    Trends in Parasitology 32:120–130.

    https://doi.org/10.1016/j.pt.2015.11.004

    • PubMed
    • Google Scholar
62. 1. Sonnenburg ED
    2. Smits SA
    3. Tikhonov M
    4. Higginbottom SK
    5. Wingreen NS
    6. Sonnenburg JL

    (2016) Diet-induced extinctions in the gut Microbiota compound over generations

    Nature 529:212–215.

    https://doi.org/10.1038/nature16504

    • PubMed
    • Google Scholar
63. 1. Spor A
    2. Koren O
    3. Ley R

    (2011) Unravelling the effects of the environment and host genotype on the gut microbiome

    Nature Reviews Microbiology 9:279–290.

    https://doi.org/10.1038/nrmicro2540

    • Google Scholar
64. 1. Springer GF
    2. Horton RE

    (1969) Blood group isoantibody stimulation in man by feeding blood group-active Bacteria

    Journal of Clinical Investigation 48:1280–1291.

    https://doi.org/10.1172/JCI106094

    • PubMed
    • Google Scholar
65. Book

    1. Stearns SC
    2. Medzhitov R

    (2015)

    Evolutionary Medicine

    Oxford University Press.

    • Google Scholar
66. 1. Sunderkötter C
    2. Nikolic T
    3. Dillon MJ
    4. Van Rooijen N
    5. Stehling M
    6. Drevets DA
    7. Leenen PJ

    (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response

    The Journal of Immunology 172:4410–4417.

    https://doi.org/10.4049/jimmunol.172.7.4410

    • PubMed
    • Google Scholar
67. 1. Takeuchi Y
    2. Porter CD
    3. Strahan KM
    4. Preece AF
    5. Gustafsson K
    6. Cosset FL
    7. Weiss RA
    8. Collins MK

    (1996) Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferase

    Nature 379:85–88.

    https://doi.org/10.1038/379085a0

    • PubMed
    • Google Scholar
68. 1. Tearle RG
    2. Tange MJ
    3. Zannettino ZL
    4. Katerelos M
    5. Shinkel TA
    6. Van Denderen BJ
    7. Lonie AJ
    8. Lyons I
    9. Nottle MB
    10. Cox T
    11. Becker C
    12. Peura AM
    13. Wigley PL
    14. Crawford RJ
    15. Robins AJ
    16. Pearse MJ
    17. d'Apice AJ

    (1996) The alpha-1,3-galactosyltransferase knockout mouse. Implications for xenotransplantation

    Transplantation 61:13–19.

    https://doi.org/10.1097/00007890-199601150-00004

    • PubMed
    • Google Scholar
69. 1. Ubeda C
    2. Lipuma L
    3. Gobourne A
    4. Viale A
    5. Leiner I
    6. Equinda M
    7. Khanin R
    8. Pamer EG

    (2012) Familial transmission rather than defective innate immunity shapes the distinct intestinal Microbiota of TLR-deficient mice

    Journal of Experimental Medicine 209:1445–1456.

    https://doi.org/10.1084/jem.20120504

    • Google Scholar
70. 1. Vincent JL
    2. Rello J
    3. Marshall J
    4. Silva E
    5. Anzueto A
    6. Martin CD
    7. Moreno R
    8. Lipman J
    9. Gomersall C
    10. Sakr Y
    11. Reinhart K
    12. EPIC II Group of Investigators

    (2009) International study of the prevalence and outcomes of infection in intensive care units

    Jama 302:2323–2329.

    https://doi.org/10.1001/jama.2009.1754

    • PubMed
    • Google Scholar
71. 1. Vonaesch P
    2. Anderson M
    3. Sansonetti PJ

    (2018) Pathogens, microbiome and the host: emergence of the ecological koch's postulates

    FEMS Microbiology Reviews 42:273–292.

    https://doi.org/10.1093/femsre/fuy003

    • PubMed
    • Google Scholar
72. 1. Wang X
    2. Grus WE
    3. Zhang J

    (2006) Gene losses during human origins

    PLOS Biology 4:e52.

    https://doi.org/10.1371/journal.pbio.0040052

    • PubMed
    • Google Scholar
73. 1. Yilmaz B
    2. Portugal S
    3. Tran TM
    4. Gozzelino R
    5. Ramos S
    6. Gomes J
    7. Regalado A
    8. Cowan PJ
    9. d'Apice AJ
    10. Chong AS
    11. Doumbo OK
    12. Traore B
    13. Crompton PD
    14. Silveira H
    15. Soares MP

    (2014) Gut Microbiota elicits a protective immune response against malaria transmission

    Cell 159:1277–1289.

    https://doi.org/10.1016/j.cell.2014.10.053

    • PubMed
    • Google Scholar
74. 1. Zeng MY
    2. Cisalpino D
    3. Varadarajan S
    4. Hellman J
    5. Warren HS
    6. Cascalho M
    7. Inohara N
    8. Núñez G

    (2016) Gut Microbiota-Induced immunoglobulin G controls systemic infection by symbiotic Bacteria and pathogens

    Immunity 44:647–658.

    https://doi.org/10.1016/j.immuni.2016.02.006

    • PubMed
    • Google Scholar

Author details

1. Sumnima Singh

   Instituto Gulbenkian de Ciência, Oeiras, Portugal

   Present address

   Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston, United States

   Contribution

   Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-1826-0180

2. Patricia Bastos-Amador

   Instituto Gulbenkian de Ciência, Oeiras, Portugal

   Present address

   Champalimaud Centre for the Unknown, Lisbon, Portugal

   Contribution

   Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing

   Contributed equally with

   Jessica Ann Thompson

   Competing interests

   No competing interests declared

3. Jessica Ann Thompson

   Instituto Gulbenkian de Ciência, Oeiras, Portugal

   Contribution

   Formal analysis, Funding acquisition, Investigation, Methodology, Writing - original draft, Writing - review and editing

   Contributed equally with

   Patricia Bastos-Amador

   Competing interests

   No competing interests declared

4. Mauro Truglio

   Instituto Gulbenkian de Ciência, Oeiras, Portugal

   Contribution

   Data curation, Formal analysis

   Competing interests

   No competing interests declared

5. Bahtiyar Yilmaz

   Instituto Gulbenkian de Ciência, Oeiras, Portugal

   Present address

   Department for Biomedical Research, Inselspital, University of Bern, Bern, Switzerland

   Contribution

   Data curation, Formal analysis, Investigation, Writing - review and editing

   Competing interests

   No competing interests declared

6. Silvia Cardoso

   Instituto Gulbenkian de Ciência, Oeiras, Portugal

   Contribution

   Formal analysis, Investigation, Methodology, Writing - review and editing

   Competing interests

   No competing interests declared

7. Daniel Sobral

   Instituto Gulbenkian de Ciência, Oeiras, Portugal

   Present address

   Universidade Nova de Lisboa, Caparica, Portugal

   Contribution

   Data curation, Software, Formal analysis, Investigation, Methodology, Writing - review and editing

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0003-3955-0117

8. Miguel P Soares

   Instituto Gulbenkian de Ciência, Oeiras, Portugal

   Contribution

   Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Investigation, Methodology, Writing - original draft, Project administration, Writing - review and editing

   For correspondence

   mpsoares@igc.gulbenkian.pt

   Competing interests

   No competing interests declared

   "This ORCID iD identifies the author of this article:" 0000-0002-9314-4833

• 1,535

  views

• 189

  downloads

• 8

  citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.